Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT-2 trial.
Sign Up to like & getrecommendations! Published in 2024 at "Addiction"
DOI: 10.1111/add.16529
Abstract: BACKGROUND AND AIMS A 12-week placebo-controlled, sequential parallel Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2) trial evaluated the effects of extended-release injectable naltrexone plus extended-release oral bupropion (NTX + BUPN) on methamphetamine (MA)… read more here.
Keywords: adapt trial; ntx bupn; trial; methamphetamine use ... See more keywords